Could cutting one amino acid make rectal cancer treatment more effective?

NCT ID NCT07755124

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether an arginine-free diet, given as a liquid formula for four weeks, can enhance the effects of standard chemoradiotherapy in people with locally advanced rectal cancer. The study first checks the diet's safety in a small group, then randomly assigns about 134 participants to receive either the diet plus chemoradiotherapy or chemoradiotherapy alone. The main goal is to see if the diet increases the chance of the tumor completely disappearing after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
An arginine-free liquid diet formula combined with short-course radiotherapy and chemotherapy
What this could lead to
If successful, this could lead to a new dietary strategy to improve tumor response and potentially increase the chance of complete remission in rectal cancer patients.
What could go wrong
This is an early-phase trial, so the diet's benefit is uncertain. It may not improve outcomes and could cause nutritional deficiencies or other side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.